Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Red maca powder (Lepidium meyenii) contains unique bioactive macamides, glucosinolates, and alkamides—identified across distinct phenotypes via advanced mass spectrometry (PMID 33410238)—that inhibit fatty acid amide hydrolase (FAAH) and modulate the endocannabinoid system, HPA axis, and Nrf2-mediated antioxidant pathways. Comprehensive phytochemical profiling reveals that red maca's phenotype-specific secondary metabolites, including aromatic glucosinolates and N-benzylamides, underpin its adaptogenic, neuroprotective, and bone-protective properties, distinguishing it from yellow and black maca varieties (PMID 27127450).
Reported Benefits (Provisional)
Origin & History
Red Maca Powder is derived from a specific phenotype of Maca (Lepidium meyenii), an adaptogenic root vegetable native to the high-altitude Andes Mountains of Peru. Revered for its unique phytochemical profile, Red Maca is particularly valued for its hormone-balancing and bone-strengthening properties. It offers significant potential in functional nutrition, supporting endocrine health, bone density, and overall vitality.
Research Narrative (Provisional)
Gonzales (2009) published a landmark review in Forschende Komplementärmedizin synthesizing traditional use and modern clinical evidence for Lepidium meyenii, documenting effects on fertility, mood, energy, and hormonal modulation across multiple human trials (PMID 20090350). Meissner et al. (2016) in the International Journal of Biomedical Science conducted detailed phytochemical profiling of four prime maca phenotypes—including red maca—grown in two geographically distinct Peruvian locations, revealing significant variation in glucosinolate, macamide, and mineral content that explains phenotype-specific health effects such as red maca's superior activity for bone density and prostate health (PMID 27127450). Perez et al. (2021) in the Journal of Mass Spectrometry applied normal and reverse-phase thin-layer chromatography coupled with DESI-MS to chemically profile and separate bioactive secondary metabolites in maca, successfully identifying macamides, macaenes, and glucosinolates as key bioactive fractions responsible for pharmacological activity (PMID 33410238). Together, these studies establish a robust scientific foundation for red maca's distinct phytochemical profile and its targeted health benefits.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Macronutrients: Plant-based Protein, Dietary Fiber - Minerals: Calcium, Magnesium, Zinc, Iron - Phytochemicals/Bioactives: Macamides, Macaenes, Glucosinolates, Polyphenols, Flavonoids
Reported Mechanism (Provisional)
Red maca's macamides—specifically N-benzylamides such as N-benzylhexadecanamide and N-benzyloctadecanamide—act as potent inhibitors of fatty acid amide hydrolase (FAAH), thereby elevating endogenous anandamide levels and enhancing endocannabinoid signaling through CB1 and CB2 receptors, which modulates mood, pain perception, and neuroinflammation. Its aromatic glucosinolates (notably glucotropaeolin and its hydrolysis product benzyl isothiocyanate) activate the Nrf2/ARE signaling pathway and downstream phase II detoxification enzymes including superoxide dismutase (SOD), catalase, and glutathione peroxidase, conferring cytoprotective and antioxidant effects. Red maca also modulates the hypothalamic-pituitary-adrenal (HPA) axis through serotonergic (5-HT) and dopaminergic pathways, normalizing cortisol output and supporting adaptive stress responses without directly supplying exogenous hormones. Additionally, its high bioavailable calcium, iron, and polyphenol content contributes to osteoblast stimulation and inhibition of osteoclast-mediated bone resorption, explaining its phenotype-specific bone-protective activity documented in preclinical models.
Clinical Narrative (Provisional)
Current evidence comes primarily from in vitro and animal studies rather than large-scale human trials. Fermented red maca showed 19.85% higher antioxidant capacity and increased total saponin content from 30.9 mg OAE/g to 65.0 mg OAE/g after 5 days. Animal models demonstrated dose-dependent enhancement of luteinizing hormone levels in female rats. Human clinical data remains limited, requiring more robust studies to establish therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.